| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Curaleaf Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$4.03 |
| 52 Week High | CA$8.73 |
| 52 Week Low | CA$3.48 |
| Beta | 1.51 |
| 11 Month Change | -5.18% |
| 3 Month Change | -28.92% |
| 1 Year Change | -24.81% |
| 33 Year Change | -70.45% |
| 5 Year Change | -51.45% |
| Change since IPO | -52.98% |
Recent News & Updates
Curaleaf Holdings, Inc. (TSE:CURA) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless
Aug 13
These 4 Measures Indicate That Curaleaf Holdings (TSE:CURA) Is Using Debt Extensively
Jul 19Recent updates
Curaleaf Holdings, Inc. (TSE:CURA) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless
Aug 13These 4 Measures Indicate That Curaleaf Holdings (TSE:CURA) Is Using Debt Extensively
Jul 19Some Confidence Is Lacking In Curaleaf Holdings, Inc. (TSE:CURA) As Shares Slide 27%
Jun 14Subdued Growth No Barrier To Curaleaf Holdings, Inc. (TSE:CURA) With Shares Advancing 25%
Jan 19Does Curaleaf Holdings (CSE:CURA) Have A Healthy Balance Sheet?
Dec 11Is Curaleaf Holdings (CSE:CURA) Using Too Much Debt?
Sep 08Curaleaf Holdings (CSE:CURA) Has Debt But No Earnings; Should You Worry?
May 28We Think Curaleaf Holdings (CSE:CURA) Is Taking Some Risk With Its Debt
Sep 05Here's Why Curaleaf Holdings (CSE:CURA) Has A Meaningful Debt Burden
May 20Is Curaleaf Holdings (CSE:CURA) A Risky Investment?
Oct 26Loss-Making Curaleaf Holdings, Inc. (CSE:CURA) Set To Breakeven
Mar 20Shareholder Returns
| CURA | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 2.3% | 0.6% | -0.3% |
| 1Y | -24.8% | -3.8% | 21.1% |
Return vs Industry: CURA underperformed the Canadian Pharmaceuticals industry which returned -3.8% over the past year.
Return vs Market: CURA underperformed the Canadian Market which returned 21.1% over the past year.
Price Volatility
| CURA volatility | |
|---|---|
| CURA Average Weekly Movement | 8.6% |
| Pharmaceuticals Industry Average Movement | 10.1% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CA Market | 17.0% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: CURA has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: CURA's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 5,650 | Boris Jordan | www.curaleaf.com |
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Curaleaf Holdings, Inc. Fundamentals Summary
| CURA fundamental statistics | |
|---|---|
| Market cap | CA$3.00b |
| Earnings (TTM) | -CA$303.27m |
| Revenue (TTM) | CA$1.86b |
1.6x
P/S Ratio-9.9x
P/E RatioIs CURA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CURA income statement (TTM) | |
|---|---|
| Revenue | US$1.36b |
| Cost of Revenue | US$732.05m |
| Gross Profit | US$627.61m |
| Other Expenses | US$848.79m |
| Earnings | -US$221.17m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 06, 2024
| Earnings per share (EPS) | -0.30 |
| Gross Margin | 46.16% |
| Net Profit Margin | -16.27% |
| Debt/Equity Ratio | 50.9% |
How did CURA perform over the long term?
See historical performance and comparison